Current Research: Retatrutide is the first triple agonist peptide targeting the Glucagon, GLP-1, and GIP receptors (3G), with EC50 values of 5.79 nM, 0.0643 nM, and 0.775 nM, respectively [1]. It is currently in the final stage of clinical trials, with many benefits that include maintaining healthy muscles.

Each capsule formulation has the added benefit of Sodium salcaprozate (SNAC) 3mg to enhance absorption. Triple power oral GLP-1 Peptide customized by adding methylated forms of Thiamin, Pyridoxine, NAD+, L-Carnitine, and vitamin B12 to help enhance insulin sensitivity and prevent loss of muscle mass.  Manufactured with approved DMF according to the Federal Food, Drug, and Cosmetic Act, to help improve energy levels, boost metabolism, and help burn fat, improve fatigue, muscle loss, or neuropathy—common concerns during weight loss or diabetes treatment—and may offer metabolic, neurological, and musculoskeletal benefits.

 Our peptides API formulations are FDA registered and not affiliated, endorsed, or intended to replace Eli Lilly, Novo Nordisk, or other companies' FDA-approved brands such as Victoza, Saxenda, Byetta, Ozempic, Rybelsus, Wegovy, Adlyxin, Trulicity, or Mounjaro.

Please do not add this item to the shopping cart, as it is contract-manufactured upon order. Contact us for minimum quantity, bulk pricing, or packaging inquiries. MQTY runs from 140,000 to 1.64MM counts.